Algert Global LLC Chimerix Inc Transaction History

Algert Global LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$2.43 - $5.42 $39,609 - $88,346	-16,300 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$2.3 - $3.72 $37,490 - $60,636	16,300 New	16,300 $41,000
Q4 2019 Feb 18, 2020	SELL	$1.3 - $2.72 $26,052 - $54,508	-20,040 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$1.93 - $4.21 $47,825 - $104,323	-24,780 Reduced 55.29%	20,040 $47,000
Q2 2019 Aug 14, 2019	BUY	$2.05 - $4.32 $91,880 - $193,622	44,820 New	44,820 $194,000

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.